VU Research Portal
Discordance between amyloid- PET and CSF biomarkers
Reimand, Juhan
2021
document version
Publisher's PDF, also known as Version of record
Link to publication in VU Research Portal
citation for published version (APA)
Reimand, J. (2021). Discordance between amyloid- PET and CSF biomarkers: Clinical and pathophysiological
consequences. Ipskamp Printing.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
E-mail address:
Discordance between amyloid-β PET and CSF
biomarkers: Clinical and pathophysiological
consequences
The studies described in this thesis were carried out in cooperation between the Alzheimer Center Amsterdam (Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC) and Department of Health Technologies (Tallinn University of Technology). Research of the Alzheimer Center is part of the Neurodegeneration program of Amsterdam Neuroscience. Printing of this thesis was supported by Stichting Alzheimer en Neuropsychiatrie.
Cover design: Juhan Reimand Layout: Juhan Reimand
Printed by: Ipskamp Printing | proefschriften.net ISBN: 978-94-6421-237-2
© Juhan Reimand, Amsterdam, the Netherlands, 2020.
All right reserved. No parts of this thesis may be reproduced, stored or transmitted in any form or by any means without prior written permission of the copyright holder, or
VRIJE UNIVERSITEIT
Discordance between amyloid-β PET and CSF biomarkers:
Clinical and pathophysiological consequences
ACADEMISCH PROEFSCHRIFT
ter verkrijging van de graad Doctor of Philosophy aan de Vrije Universiteit Amsterdam en Tallinn University of Technology,
op gezag van de rectores magnifici prof.dr. V. Subramaniam en prof.dr. T. Land,
in het openbaar te verdedigen ten overstaan van de promotiecommissie
van de Faculteit der Geneeskunde op woensdag 12 mei 2021 om 13.45 uur
in de aula van de universiteit, De Boelelaan 1105
door Juhan Reimand geboren te Tallinn, Estland
promotoren: prof.dr. Ph. Scheltens dr. R. Ossenkoppele prof.dr. B.N.M. van Berckel copromotoren: dr. F Bouwman
TALLINN UNIVERSITY OF TECHNOLOGY
DOCTORAL THESIS
15/2021
Discordance between amyloid-β
PET and CSF biomarkers:
Clinical and pathophysiological
consequences
TALLINN UNIVERSITY OF TECHNOLOGY School of Information Technologies
Department of Health Technologies
This dissertation was accepted for the defence of the degree 16/10/2020
Supervisors: Prof. Sergei Nazarenko, MD, PhD
Department of Health Technologies Tallinn University of Technology Tallinn, Estonia
Prof. Philip Scheltens, MD, PhD Faculty of Medicine
VUMC Alzheimer Center, Amsterdam UMC Vrije Universiteit Amsterdam
Amsterdam, the Netherlands
Opponents: Assoc. Prof. Pilvi Ilves, MD, PhD
Department of Radiology Institute of Clinical Medicine University of Tartu
Tartu, Estonia
Dr. Elsmarieke van de Giessen, MD, PhD Department of Nuclear Medicine
Academic Medical Center, Amsterdam UMC University of Amsterdam
Amsterdam, the Netherlands
Defence of the thesis:12/05/2021, Amsterdam
Declaration:
Hereby I declare that this doctoral thesis, my original investigation and achievement, submitted for the joint doctoral degree at Tallinn University of Technology and at Vrije Universiteit Amsterdam has not been submitted for doctoral or equivalent academic degree.
Juhan Reimand
signature
Copyright: Juhan Reimand, 2020 ISSN 2585-6898 (publication) ISSN 2585-6901 (PDF)
